According to the discussion, which statement describes how the medicalization of deviance affects industry?

• A. Insurers are the primary beneficiaries of defined illnesses.
• B. Doctors' fees determine the spread of medicalization.
• C. Pharmaceutical companies make billions treating illnesses such as fatigue, insomnia, and hyperactivity that may not actually be illnesses in need of treatment.
• D. Patients personally benefit most from illness labels.

Answer: (C)

Medicalization of deviance expands medicine’s reach by turning more behaviors and social differences into medical diagnoses, which in turn creates lucrative markets for treatments. When fatigue, sleep problems, or attention difficulties are redefined as medical illnesses, a larger segment of the population becomes a potential customer for drugs and related therapies. This dynamic explains why the statement about pharmaceutical companies making billions by treating these conditions fits best: it captures the profit-driven side of medicalization, where industry interests help shape what counts as illness and how it’s treated.

The other ideas miss this central point. Insurers may have a stake, but the emphasis in the discussion is on how drug companies profit from new illness labels. Doctors’ fees can influence practice patterns, but they don’t define the scale of the industry’s expansion as directly. And while patients can benefit in some cases, the framing here highlights industry gain more than patient-wide benefit.